These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31178274)

  • 1. Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
    Huffman BM; Jin Z; Yadav S; Patel S; Nagorney DM; Truty MJ; McWilliams RR; Halfdanarson TR; Mahipal A
    Clin Colorectal Cancer; 2019 Sep; 18(3):218-225. PubMed ID: 31178274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.
    Aydin D; Sendur MA; Kefeli U; Unal OU; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Ustaalioglu BB; Uysal M; Esbag O; Yazilitas D; Tanrıverdi O; Bilici A; Arpaci E; Berk V; Yetisyigit T; Ozdemir NY; Oztop I; Alacacioglu A; Aydin O; Ozcelik M; Yildirim E; Dinc N; Gumus M
    Clin Colorectal Cancer; 2017 Sep; 16(3):220-227. PubMed ID: 27670893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
    Overman MJ; Kopetz S; Lin E; Abbruzzese JL; Wolff RA
    Acta Oncol; 2010 May; 49(4):474-9. PubMed ID: 20397775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence and Survival Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Small Bowel Adenocarcinoma.
    Saxena A; Valle SJ; Liauw W; Morris DL
    Anticancer Res; 2017 Oct; 37(10):5737-5742. PubMed ID: 28982894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.
    Jin Z; Hartgers ML; Sanhueza CT; Shubert CR; Alberts SR; Truty MJ; Muppa P; Nagorney DM; Smyrk TC; Hassan M; Mahipal A
    Eur J Surg Oncol; 2018 May; 44(5):677-683. PubMed ID: 29506768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).
    Aydin D; Sendur MA; Kefeli U; Umut Unal O; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Bala Ustaalioglu B; Sener Dede D; Esbag O; Inal A; Bilir C; Bilici A; Harputlu H; Berk V; Sevinc A; Yildirim Ozdemir N; Yildirim E; Sonkaya A; Ali Ustaoglu M; Gumus M
    J BUON; 2016; 21(5):1242-1249. PubMed ID: 27837629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
    Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
    Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.
    Young JI; Mongoue-Tchokote S; Wieghard N; Mori M; Vaccaro GM; Sheppard BC; Tsikitis VL
    Dis Colon Rectum; 2016 Apr; 59(4):306-15. PubMed ID: 26953989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.
    Ecker BL; McMillan MT; Datta J; Mamtani R; Giantonio BJ; Dempsey DT; Fraker DL; Drebin JA; Karakousis GC; Roses RE
    Cancer; 2016 Mar; 122(5):693-701. PubMed ID: 26717303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients.
    Aparicio T; Henriques J; Manfredi S; Tougeron D; Bouché O; Pezet D; Piessen G; Coriat R; Zaanan A; Legoux JL; Terrebone E; Pocard M; Gornet JM; Lecomte T; Lombard-Bohas C; Perrier H; Lecaille C; Lavau-Denes S; Vernerey D; Afchain P;
    Int J Cancer; 2020 Aug; 147(4):967-977. PubMed ID: 31912484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators.
    Moon YW; Rha SY; Shin SJ; Chang H; Shim HS; Roh JK
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):387-94. PubMed ID: 19760196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4.
    el Aziz LM
    Med Oncol; 2014 Dec; 31(12):311. PubMed ID: 25367855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of tumor site on the prognosis of small bowel adenocarcinoma.
    Falcone R; Romiti A; Filetti M; Roberto M; Righini R; Botticelli A; Pilozzi E; Ghidini M; Pizzo C; Mazzuca F; Marchetti P
    Tumori; 2019 Dec; 105(6):524-528. PubMed ID: 30935289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of small bowel adenocarcinoma in Crohn's disease compares favourably with de novo small bowel adenocarcinoma.
    Wieghard N; Mongoue-Tchokote S; Young JI; Sheppard BC; Tsikitis VL
    Colorectal Dis; 2017 May; 19(5):446-455. PubMed ID: 27659145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
    Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
    Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
    Gulhati P; Raghav K; Shroff RT; Varadhachary GR; Kopetz S; Javle M; Qiao W; Wang H; Morris J; Wolff RA; Overman MJ
    Cancer; 2017 May; 123(6):1011-1017. PubMed ID: 27859010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of surgery and chemotherapy for stage IV small bowel adenocarcinoma: A population-based analysis using Surveillance, Epidemiology, and End Result Program database.
    Liu T; Wu Y; Jiang T
    Cancer Med; 2020 Sep; 9(18):6638-6645. PubMed ID: 32750232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.
    Wang ZX; Yang XL; He MM; Wang F; Zhang DS; Li YH; Zhou ZW; Zhan YQ; Xu RH
    Medicine (Baltimore); 2016 Apr; 95(16):e3214. PubMed ID: 27100411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.